Table 1 Key questions to inform an update of recommendations by the Task Force on screening for depression among children and adolescents
Key questions (KQs) | |
|---|---|
KQ1 | What are the benefits and harms of screening for depression in children (6 to 11 years old) and adolescents (12 to 17 years old) in primary care or other non-mental health clinic settings? |
KQ1a | What are the benefits and harms of screening for depression in children (6 to 11 years old) and adolescents (12 to 17 years old) in primary care or other non-mental health clinic settings for patients targeted because they have characteristics that may suggest elevated risk of depression? |